LSL Pharma Group Inc.

TSXV:LSL Stock Report

Market Cap: CA$46.8m

LSL Pharma Group Management

Management criteria checks 0/4

LSL Pharma Group's CEO is Francois Roberge, appointed in Feb 2023, has a tenure of 1.92 years. directly owns 19.7% of the company’s shares, worth CA$9.22M. The average tenure of the management team and the board of directors is 1.1 years and 1.9 years respectively.

Key information

Francois Roberge

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.9yrs
CEO ownership19.7%
Management average tenure1.1yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

Not Many Are Piling Into LSL Pharma Group Inc. (CVE:LSL) Stock Yet As It Plummets 26%

Dec 14
Not Many Are Piling Into LSL Pharma Group Inc. (CVE:LSL) Stock Yet As It Plummets 26%

CEO Compensation Analysis

How has Francois Roberge's remuneration changed compared to LSL Pharma Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$2m

Jun 30 2024n/an/a

-CA$3m

Mar 31 2024n/an/a

-CA$3m

Dec 31 2023n/an/a

-CA$8m

Sep 30 2023n/an/a

-CA$10m

Jun 30 2023n/an/a

-CA$11m

Mar 31 2023n/an/a

-CA$12m

Dec 31 2022n/an/a

-CA$8m

Sep 30 2022n/an/a

-CA$6m

Dec 31 2021CA$200kCA$200k

-CA$2m

Compensation vs Market: Insufficient data to establish whether Francois's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Francois's compensation with company performance.

CEO

Francois Roberge (59 yo)

1.9yrs

Tenure

CA$200,000

Compensation

Mr. Francois Roberge is President and Chief Executive Officer and director of LSL Pharma Group Inc. (formerly ILedor Exploration Corporation) since February 22, 2023 and serves as its Chairman. Mr. Roberge...

Leadership Team

NamePositionTenureCompensationOwnership
Francois Roberge
Chairman1.9yrsCA$200.00k19.7%
CA$ 9.2m
Marc Boudreault
Vice-President of Communicationsno dataCA$138.00kno data
Mélanie St-Pierre
Corporate Controllerno dataCA$6.64kno data
Luc Mainville
CFO & Senior VP1.1yrsno data0.76%
CA$ 354.4k
Francis Chenard
Senior VP & COOno datano datano data
Guy Allard
Vice Presidentless than a yearno datano data

1.1yrs

Average Tenure

Experienced Management: LSL's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Francois Roberge
Chairman1.9yrsCA$200.00k19.7%
CA$ 9.2m
Frank DellaFera
Director1.9yrsno data1.12%
CA$ 523.6k
Mario Paradis
Directorless than a yearno data0.22%
CA$ 101.3k
Alain Larochelle
Director1.9yrsno datano data
Sylvain Aird
Director1.9yrsno datano data
Diane Beaudry
Directorless than a yearno datano data
Stuart Fowler
Directorless than a yearno datano data
Pierre Lafreniere
Director1.9yrsno datano data
Joseph Soccodato
Directorless than a yearno datano data

1.9yrs

Average Tenure

59yo

Average Age

Experienced Board: LSL's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 13:03
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LSL Pharma Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution